Search Results for: CONTRACT MANUFACTURING Delivering Market Success
Articles
CONTRACT MANUFACTURING - Delivering Market Success & ROI to Pharmaceutical Partners May 31, 2017
Mike Schaefers, PhD, and Mike Treadaway say more than ever, contract manufacturing must deliver continuous innovation and flexibility to accommodate the delivery of a wide range of drugs throughout each therapy’s lifecycle.
SPECIAL FEATURE- Outsourcing Formulation Development & Manufacturing: CDMOs Are Making Their Supply Chains More Resilient & Secure June 4, 2025
Contributor Cindy H. Dubin speaks with many CDMO professionals to get their insights and perspectives on the current state of the industry.
CONTRACT SERVICES - When Choosing Stent, Catheter & Tubing Partners, Less is More May 6, 2025
Andrew Filachek says the ability to combine ideation and early stage development with materials science and process technologies has, in recent years, become a differentiator across a variety of device categories.
Symbiosis Announces Acquisition of New Facility & Investment in Automated Commercial-Scale GMP Sterile Manufacturing Capability September 9, 2024
Symbiosis Pharmaceutical Services Ltd (Symbiosis), a rapidly growing sterile biopharmaceutical Contract Manufacturing Organization (CMO) announces the purchase of new premises...AGC Biologics & BioConnection Partner to Offer New End-to-End Biopharmaceutical Drug Substance & Drug Product Development & Manufacturing Offering May 22, 2024
AGC Biologics and BioConnection recently announced a new strategic partnership. The companies are partnering to provide end-to-end biopharmaceutical development and...4BIO Capital Portfolio Company Ascend Acquires Florida-Based GMP Manufacturing Capacity April 9, 2024
Long-Term Partnership Agreed with Beacon Therapeutics for Clinical and Commercial AAV Production….
Enzene Biosciences Launches its First Manufacturing Base in the US, With Additional Plans to Establish Continuous Manufacturing Operations at its New Jersey Site January 8, 2024
Widely recognized as a pioneer in continuous manufacturing, Pune-based Contract Development & Manufacturing Organization (CDMO), Enzene Biosciences has announced the launch of its first manufacturing site in the US, located in….
EXECUTIVE INTERVIEW - Credence MedSystems: Implementing a Flexible Manufacturing Line to Deliver Innovation in Drug Delivery to the Pharmaceutical Industry October 3, 2022
Jeffrey Tillack, Chief Operating Officer at Credence MedSystems, discusses the challenges being addressed by his innovative technology and the role its new Flex Line will play in the company’s scaling strategy.
Pace Life Sciences Acquires Biopharma Global, Expanding FDA Regulatory Affairs Strategy & Consulting Capabilities to the Biotechnology & Pharmaceutical Markets September 8, 2022
Pace Life Sciences, LLC recently announced it has acquired Biopharma Global (Biopharma). Biopharma specializes in full-service regulatory support for orphan...EXECUTIVE INTERVIEW - Emergent CDMO: A Molecule-to-Market Partner for Complex Biologics August 31, 2022
Bill Hartzel, Senior Vice President and Head of CDMO Business, discusses the company’s plans for current and future CDMO operations and client partnership opportunities.
SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Understanding Critical Attributes Earlier in Development Leads to a More Robust Drug Product June 1, 2022
Contributor Cindy H. Dubin speaks with industry leaders on how drug sponsors and CDMOs are collaborating earlier, and highlights how third-party contractors are navigating material shortages and how the industry is shifting to address different therapeutic targets and molecules, such as mRNA.
EXECUTIVE INTERVIEW - Catalent: Developing & Delivering Billions of Doses of Drugs Every Year June 1, 2022
Alessandro Maselli, President and Chief Operating Officer of Catalent, talks about his company’s unique approach to drug development partnerships as he prepares to become the company’s new President and Chief Executive Officer on July 1, 2022.
Rentschler Biopharma & Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration March 29, 2022
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), recently announced they are unveiling Xpert Alliance,...TriRx Completes Acquisition of Elanco Manufacturing Facility in Speke, UK February 9, 2022
TriRx Pharmaceutical Services, LLC, a leading international CDMO, recently announced it has finalized and closed on its agreement with Elanco Animal Health Incorporated to acquire the ownership and operations of….
Metrics Contract Services Appoints Commercial Manufacturing BD Lead January 4, 2022
Metrics Contract Services, a full-service contract development and manufacturing organization (CDMO) in novel oral solid dose (OSD) products, has appointed...Metrics Contract Services Completes ANVISA Regulatory Inspection November 19, 2021
Metrics Contract Services, a division of Mayne Pharma, recently announced its Greenville, NC, facility has successfully completed an inspection by...Metrics Contract Services Enters Partnership to Develop Oncology Drug October 6, 2021
Metrics Contract Services, the US-based contract pharmaceutical development and manufacturing division of Mayne Pharma, recently announced the signing of a development and manufacturing agreement with….
GENE THERAPY - Solving the Puzzle: Aligning the Pieces of Gene Therapy & Creating Success for Patients August 26, 2021
Sue Washer, MBA, reviews the various elements that must come together in developing safe, effective, and commercially viable viral-based gene therapies.
Metrics Contract Services Expands With New Suites & Equipment August 4, 2021
Metrics Contract Services (Metrics), a full-service global contract development and manufacturing organization (CDMO), has recently expanded its novel oral solid dose commercial facility in Greenville, NC, adding 3,760….
SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Meeting Demand for Biologics & Specialty Drugs June 2, 2021
Contributor Cindy Dubin highlights the formulation development and manufacturing offerings from some of the leading CDMOs to address a myriad of challenges – from complex compounds to poor solubility to dual-release profiles.
